Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
Alexander C PerinoJun FanSusan SchmittJennifer D GuoPatrick HlavacekNatasha DinMitra KothariKrishna N PundiCristina RussBirol EmirMintu P TurakhiaPublished in: Circulation. Cardiovascular quality and outcomes (2021)
Patients ≥120 kg and ≥40 kg/m2 with VTE are frequently prescribed DOAC by the Veterans Health Administration, without an increase in bleeding or recurrent VTE. These findings suggest DOACs can be safe and effective in this population and may argue for broader adoption of pharmacy policies that promote careful patient selection and shared decision making.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- body mass index
- public health
- healthcare
- end stage renal disease
- mental health
- ejection fraction
- atrial fibrillation
- newly diagnosed
- weight gain
- chronic kidney disease
- physical activity
- health information
- weight loss
- health promotion
- type diabetes
- peritoneal dialysis
- human health
- skeletal muscle
- electronic health record
- adipose tissue
- body weight
- social media
- insulin resistance